Biocryst Pharmaceuticals (BCRX) Return on Assets (2011 - 2026)

Biocryst Pharmaceuticals has reported Return on Assets for 16 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 1.0% YoY), and the FY2025 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
• The five-year high for Return on Assets was 0.01% in Q4 2025, with the low at 0.01% in Q1 2026.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• Annual changes were most pronounced in 2025 — Return on Assets gained 1 bps — and 2026, when it slipped 1 bps.
• Biocryst Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then rose by 2 bps to 0.0% in 2023, then surged by 58 bps to 0.0% in 2024, then soared by 403 bps to 0.01% in 2025, then sank by 270 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.